person · Reporting owner
Daglio David Angelo Jr.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alkermes plc.ALKS · Entity 2392 | Director | June 29, 2024 | July 01, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alkermes plc.
Report date June 29, 2024 · Filed July 01, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 27,780 |
Ending reported balance
After 2024-06-29 transaction · row 3
2 source rows · reconciled sequenceRow 2 · 2024-06-29 · Exercise / conversion · Acquired 6,104 · Balance 29,245 F2: Each restricted stock unit represents a contingent right to receive one ordinary share. Row 3 · 2024-06-29 · Tax withholding · Disposed 1,465 · Balance 27,780 |
| Restricted Stock Unit AwardSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-06-29 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-06-29 · Exercise / conversion · Disposed 6,104 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one ordinary share. F3: This award is fully vested in accordance with its terms. |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy the Daglio Trust | 80,000 |
Reported balance
Holding disclosure · report date 2024-06-29 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 80,000 F1: Shares are held by The David A Daglio Jr Trust U/A 09/21/17 (the "Daglio Trust"), of which the reporting person is both sole trustee and sole beneficiary. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares are held by The David A Daglio Jr Trust U/A 09/21/17 (the "Daglio Trust"), of which the reporting person is both sole trustee and sole beneficiary.
F2: Each restricted stock unit represents a contingent right to receive one ordinary share.
F3: This award is fully vested in accordance with its terms.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 29, 2024 Filed Jul 1, 2024 20:54 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019590 · form4.xml · derivative · entry 4 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: This award is fully vested in accordance with its terms. F3 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 20:54 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 1,465 | $24.10 | $35,306.50 |
DisclosureSEC source: 0001127602-24-019590 · form4.xml · nonDerivative · entry 3 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,780 Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 20:54 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019590 · form4.xml · nonDerivative · entry 2 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,245 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:51 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 17,492 | $0.00 Strike: $23.40 | $0.00 |
DisclosureSEC source: 0001127602-24-017720 · form4.xml · derivative · entry 2 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,492 Underlying: Ordinary Shares · 17,492 shares Expires 2034-05-31 F3 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:51 UTC | Alkermes plc. ALKS · Entity 2392 | GrantRestricted Stock Unit Award · Derivative | 8,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017720 · form4.xml · derivative · entry 1 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,013 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. Read SEC document |
| February 10, 2024 Filed Feb 13, 2024 22:07 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 4,533 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-004738 · form4.xml · derivative · entry 11 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,533 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F5 · derivative.exercise_date: This award is fully vested in accordance with its terms. F5 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| February 10, 2024 Filed Feb 13, 2024 22:07 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 1,088 | $27.32 | $29,724.16 |
DisclosureSEC source: 0001127602-24-004738 · form4.xml · nonDerivative · entry 2 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,141 Read SEC document |
| February 10, 2024 Filed Feb 13, 2024 22:07 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 4,533 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-004738 · form4.xml · nonDerivative · entry 1 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| November 17, 2023 Filed Feb 13, 2024 22:07 UTC | Alkermes plc. ALKS · Entity 2392 | OtherRestricted Stock Unit Award · Derivative | 119 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-004738 · form4.xml · derivative · entry 10 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,104 Underlying: Ordinary Shares · 119 shares Expires not disclosed F3 · security: Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the "Separation"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F7 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 6/29/2024. F7 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 6/29/2024. Read SEC document |
| November 17, 2023 Filed Feb 13, 2024 22:07 UTC | Alkermes plc. ALKS · Entity 2392 | OtherNon Qualified Stock Option (Right to Buy) · Derivative | 254 | $30.72 Strike: $30.72 | $7,802.88 |
DisclosureSEC source: 0001127602-24-004738 · form4.xml · derivative · entry 9 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,986 Underlying: Ordinary Shares · 254 shares Expires 2033-06-29 F3 · security: Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the "Separation"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5. F6 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 6/29/2024. Read SEC document |
| November 17, 2023 Filed Feb 13, 2024 22:07 UTC | Alkermes plc. ALKS · Entity 2392 | OtherNon Qualified Stock Option (Right to Buy) · Derivative | 231 | $30.86 Strike: $30.86 | $7,128.66 |
DisclosureSEC source: 0001127602-24-004738 · form4.xml · derivative · entry 8 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,785 Underlying: Ordinary Shares · 231 shares Expires 2032-07-07 F3 · security: Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the "Separation"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| November 17, 2023 Filed Feb 13, 2024 22:07 UTC | Alkermes plc. ALKS · Entity 2392 | OtherNon Qualified Stock Option (Right to Buy) · Derivative | 313 | $24.24 Strike: $24.24 | $7,587.12 |
DisclosureSEC source: 0001127602-24-004738 · form4.xml · derivative · entry 7 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,990 Underlying: Ordinary Shares · 313 shares Expires 2031-06-14 F3 · security: Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the "Separation"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| November 17, 2023 Filed Feb 13, 2024 22:07 UTC | Alkermes plc. ALKS · Entity 2392 | OtherRestricted Stock Unit Award · Derivative | 88 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-004738 · form4.xml · derivative · entry 6 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,533 Underlying: Ordinary Shares · 88 shares Expires not disclosed F3 · security: Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the "Separation"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F5 · derivative.exercise_date: This award is fully vested in accordance with its terms. F5 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| November 17, 2023 Filed Feb 13, 2024 22:07 UTC | Alkermes plc. ALKS · Entity 2392 | OtherNon Qualified Stock Option (Right to Buy) · Derivative | 523 | $22.48 Strike: $22.48 | $11,757.04 |
DisclosureSEC source: 0001127602-24-004738 · form4.xml · derivative · entry 5 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,692 Underlying: Ordinary Shares · 523 shares Expires 2031-02-10 F3 · security: Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the "Separation"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| November 17, 2023 Filed Feb 13, 2024 22:07 UTC | Alkermes plc. ALKS · Entity 2392 | OtherNon Qualified Stock Option (Right to Buy) · Derivative | 90 | $22.48 Strike: $22.48 | $2,023.20 |
DisclosureSEC source: 0001127602-24-004738 · form4.xml · derivative · entry 4 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,639 Underlying: Ordinary Shares · 90 shares Expires 2031-02-10 F3 · security: Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the "Separation"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| July 07, 2023 Filed Jul 11, 2023 00:29 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 5,957 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020546 · form4.xml · derivative · entry 4 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,957 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: This award is fully vested in accordance with its terms. F3 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| July 07, 2023 Filed Jul 11, 2023 00:29 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 1,430 | $29.88 | $42,728.40 |
DisclosureSEC source: 0001127602-23-020546 · form4.xml · nonDerivative · entry 2 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,696 Read SEC document |
| July 07, 2023 Filed Jul 11, 2023 00:29 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 5,957 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020546 · form4.xml · nonDerivative · entry 1 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| June 29, 2023 Filed Jun 30, 2023 20:31 UTC | Alkermes plc. ALKS · Entity 2392 | GrantRestricted Stock Unit Award · Derivative | 5,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-019625 · form4.xml · derivative · entry 2 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,985 Underlying: Ordinary Shares · 5,985 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 6/29/2024. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 6/29/2024. Read SEC document |
| June 29, 2023 Filed Jun 30, 2023 20:31 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 12,732 | $0.00 Strike: $31.33 | $0.00 |
DisclosureSEC source: 0001127602-23-019625 · form4.xml · derivative · entry 1 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,732 Underlying: Ordinary Shares · 12,732 shares Expires 2033-06-29 F1 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 6/29/2024. Read SEC document |
| February 10, 2023 Filed Feb 11, 2023 01:01 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 4,445 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-004584 · form4.xml · derivative · entry 3 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,445 Underlying: Ordinary Shares · 4,445 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in three equal annual installments, commencing on 2/10/2022. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in three equal annual installments, commencing on 2/10/2022. Read SEC document |
| February 10, 2023 Filed Feb 11, 2023 01:01 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 4,445 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-004584 · form4.xml · nonDerivative · entry 1 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| November 14, 2022 Filed Nov 16, 2022 21:13 UTC | Alkermes plc. ALKS · Entity 2392 | PurchaseOrdinary Shares | 35,000 | $23.31 | $815,734.50 |
DisclosureSEC source: 0001127602-22-025746 · form4.xml · nonDerivative · entry 1 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By the Daglio Trust Disclosed balance after: 80,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $22.82 to $23.57. Full information regarding the number of shares purchased at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. F2 · ownership.nature: Shares are held by The David A Daglio Jr Trust U/A 09/21/17 (the "Daglio Trust"), of which the reporting person is both sole trustee and sole beneficiary. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 20:20 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 11,554 | $0.00 Strike: $31.48 | $0.00 |
DisclosureSEC source: 0001127602-22-019128 · form4.xml · derivative · entry 2 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,554 Underlying: Ordinary Shares · 11,554 shares Expires 2032-07-07 F3 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 7/7/2023. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 20:20 UTC | Alkermes plc. ALKS · Entity 2392 | GrantRestricted Stock Unit Award · Derivative | 5,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019128 · form4.xml · derivative · entry 1 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,957 Underlying: Ordinary Shares · 5,957 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 7/7/2023. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 7/7/2023. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:55 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 7,585 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-017635 · form4.xml · derivative · entry 4 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,585 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: This award is fully vested in accordance with its terms. F3 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:55 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 795 | $27.19 | $21,616.05 |
DisclosureSEC source: 0001127602-22-017635 · form4.xml · nonDerivative · entry 2 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,724 Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:55 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 7,585 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-017635 · form4.xml · nonDerivative · entry 1 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:34 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 2,223 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-004568 · form4.xml · derivative · entry 7 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,223 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F4 · derivative.exercise_date: This restricted stock unit award vested in full on 2/10/2022. F4 · derivative.expiration_date: This restricted stock unit award vested in full on 2/10/2022. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:34 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 4,446 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-004568 · form4.xml · derivative · entry 6 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,890 Underlying: Ordinary Shares · 4,446 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in three equal annual installments, commencing on 2/10/2022. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in three equal annual installments, commencing on 2/10/2022. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:34 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 912 | $23.55 | $21,477.60 |
DisclosureSEC source: 0001127602-22-004568 · form4.xml · nonDerivative · entry 4 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,934 Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:34 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 2,223 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-004568 · form4.xml · nonDerivative · entry 3 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:34 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 1,823 | $23.55 | $42,931.65 |
DisclosureSEC source: 0001127602-22-004568 · form4.xml · nonDerivative · entry 2 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,623 Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:34 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 4,446 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-004568 · form4.xml · nonDerivative · entry 1 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:22 UTC | Alkermes plc. ALKS · Entity 2392 | GrantRestricted Stock Unit Award · Derivative | 7,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020038 · form4.xml · derivative · entry 2 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585 Underlying: Ordinary Shares · 7,585 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:22 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 15,677 | $0.00 Strike: $24.72 | $0.00 |
DisclosureSEC source: 0001127602-21-020038 · form4.xml · derivative · entry 1 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,677 Underlying: Ordinary Shares · 15,677 shares Expires 2031-06-14 F1 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 6/14/2022. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 22:30 UTC | Alkermes plc. ALKS · Entity 2392 | GrantRestricted Stock Unit Award · Derivative | 2,223 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005259 · form4.xml · derivative · entry 4 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,223 Underlying: Ordinary Shares · 2,223 shares Expires not disclosed F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 2/10/2022. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 2/10/2022. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 22:30 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 4,549 | $0.00 Strike: $22.93 | $0.00 |
DisclosureSEC source: 0001127602-21-005259 · form4.xml · derivative · entry 3 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,549 Underlying: Ordinary Shares · 4,549 shares Expires 2031-02-10 F3 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 2/10/2022. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 22:30 UTC | Alkermes plc. ALKS · Entity 2392 | GrantRestricted Stock Unit Award · Derivative | 13,336 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005259 · form4.xml · derivative · entry 2 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,336 Underlying: Ordinary Shares · 13,336 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in three annual installments commencing on 2/10/2022. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in three annual installments commencing on 2/10/2022. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 22:30 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 26,169 | $0.00 Strike: $22.93 | $0.00 |
DisclosureSEC source: 0001127602-21-005259 · form4.xml · derivative · entry 1 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,169 Underlying: Ordinary Shares · 26,169 shares Expires 2031-02-10 F1 · derivative.exercise_date: Shares subject to the stock option award vest in three annual installments commencing on 2/10/2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.